More Clinuvel Pharmaceuticals Limited news
Clinuvel Pharmaceuticals LimitedASX: CUV

ACTH Manufacturing Update

Mar 16, 2022 at 10:54 PM EDT · Issued by Clinuvel Pharmaceuticals Limited

Filed with ASX · Mar 16, 2022 at 10:54 PM EDT

On 6ix: 6ix.com/news/acth-manufacturing-update

Watch Clinuvel Pharmaceuticals' latest call↗Clinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call · Replay · Aug 27Read the transcript of Clinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call↗

Clinuvel Pharmaceuticals Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Clinuvel Pharmaceuticals Limited on 6ix

Earlier from Clinuvel Pharmaceuticals

  • afamelanotide in Stroke (AIS) - Positive Preliminary ResultsMar 14, 2022
  • CLINUVEL Reports December Half Year Operating ResultsFeb 22, 2022
  • Appendix 4D Half Year ReportFeb 22, 2022
  • Response to ASX Price QueryNov 7, 2021
  • CLINUVEL Delivers Record Revenues and ProfitAug 26, 2021

Later from Clinuvel Pharmaceuticals

  • Positive Final Results in Stroke Study CUV801May 3, 2022
  • Appendix 4E and Annual Report 2022Aug 30, 2022
  • S&P DJI Announces September 2022 Quarterly RebalanceSep 2, 2022
  • Quarterly Activities/Appendix 4C Cash Flow Report Re-issuedOct 30, 2022
  • Quarterly Activities/Appendix 4C Cash Flow ReportJan 30, 2023
All Clinuvel Pharmaceuticals news releases↗

Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.

Follow Clinuvel Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer